Skip to main content
. Author manuscript; available in PMC: 2014 Aug 18.
Published in final edited form as: CNS Drugs. 2013 Aug;27(8):663–673. doi: 10.1007/s40263-013-0082-x

Table 3.

Catechol-O-methyltransferase (COMT) enzyme activity measured 4 h after treatment (placebo or tolcapone)

CMT
genotype
Drug COMT activity (cpm/mg protein)
Mean ± SD Range
Val/Val Placebo 194606.8 ± 33248.95 166183.6–240754.2
Val/Val Tolcapone 162443.3 ± 42447.9 98857.8–186635.7
Val/Met Placebo 106242.8 ± 36605.0 79724.1–166394.7
Val/Met Tolcapone 97566.0 ± 39667.6 64850.6–165318.1
Met/Met Placebo 47434.5 ± 11837.6 29641.5–61988.2
Met/Met Tolcapone 51938.4 ± 13999.1 38355.1–82681.4